Detalles de la búsqueda
1.
A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant.
PLoS Pathog
; 18(4): e1010465, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35482816
2.
A broadly neutralizing monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV-2 variants of concern.
PLoS Pathog
; 18(12): e1010994, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36508467
3.
Trends of humoral immune responses to heterologous antigenic exposure due to vaccination & omicron SARS-CoV-2 infection: Implications for boosting.
Indian J Med Res
; 157(6): 509-518, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37322634
4.
Characterization of the NiRAN domain from RNA-dependent RNA polymerase provides insights into a potential therapeutic target against SARS-CoV-2.
PLoS Comput Biol
; 17(9): e1009384, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34516563
5.
Targeting DPP4-RBD interactions by sitagliptin and linagliptin delivers a potential host-directed therapy against pan-SARS-CoV-2 infections.
Int J Biol Macromol
; 245: 125444, 2023 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37385308
6.
Characterization of a broadly cross reactive tetravalent human monoclonal antibody, recognizing conformational epitopes in receptor binding domain of SARS-CoV-2.
3 Biotech
; 12(9): 202, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35928502
7.
High failure rate of ChAdOx1-nCoV19 immunization against asymptomatic infection in healthcare workers during a Delta variant surge.
Nat Commun
; 13(1): 1726, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35365648
8.
Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model.
Front Immunol
; 12: 641447, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34108961
9.
The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41.
Int Immunopharmacol
; 101(Pt B): 108187, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34649114
10.
Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus.
Int Immunopharmacol
; 99: 108020, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34426117
11.
Resultados
1 -
11
de 11
1
Próxima >
>>